New drug tested to help kids with ADHD and aggressive behavior
NCT ID NCT00626236
Summary
This study tested the safety and different dose levels of an investigational drug called SPN-810 in children with ADHD who also had serious, persistent conduct problems like fighting or destroying property. It involved 78 children aged 6 to 12 over several months. The main goal was to see how well the drug was tolerated and if it could help reduce disruptive behaviors and ADHD symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alliance Research Group
Richmond, Virginia, 23229, United States
-
CNS Healthcare
Orlando, Florida, 32806, United States
-
Capstone Clinical Research
Libertyville, Illinois, 60048, United States
-
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, 38119, United States
-
Florida Clinical Research Center
Bradenton, Florida, 32408, United States
-
IPS Research
Oklahoma City, Oklahoma, 73103, United States
-
Northwest Clinical Trials
Bellevue, Washington, 98004, United States
-
Sarkis Clinical Trials
Gainesville, Florida, 32607, United States
-
The Psychopharm Research Cntr - LSU Dept of Psychiatry
Shreveport, Louisiana, 71103, United States
Conditions
Explore the condition pages connected to this study.